M&A Advisor for Orthopedic Practice Owners: 2026 Sell-Side Guide

By Christoph Totter, CT Acquisitions Managing Partner. Last reviewed: July 2026.

An M&A advisor for an orthopedic practice is a sell-side banker who runs a competitive process to convert a physician-owned clinical entity, its ambulatory surgery center (ASC) interests, physical therapy (PT), imaging, and durable medical equipment (DME) revenue streams into a management services organization (MSO) transaction with a private equity platform or a physician-owned super group. The advisor’s job in 2026 is to organize the ancillary stack, defend the referral pattern through a Stark and Anti-Kickback lens, and secure a corporate practice of medicine (CPOM) compliant structure that preserves clinical autonomy while getting the owners paid for enterprise value that a solo practice cannot capture on its own.

Executive Summary

Orthopedic MSO consolidation is in wave 2, with named platforms including Muve Health backed by NexPhase Capital , OrthoAlliance backed by Revelstoke Capital Partners , Beacon Orthopaedics backed by Varsity Healthcare Partners , U.S. Orthopaedic Partners backed by FFL Partners , and the physician-owned super group EmergeOrtho in North Carolina. The valuation composition of an orthopedic practice would shift materially when ASC, PT, imaging, and DME ancillaries are unbundled and.

• Orthopedic MSO consolidation is in wave 2, with named platforms including Muve Health backed by NexPhase Capital, OrthoAlliance backed by Revelstoke Capital Partners, Beacon Orthopaedics backed by Varsity Healthcare Partners, U.S. Orthopaedic Partners backed by FFL Partners, and the physician-owned super group EmergeOrtho in North Carolina.
• The valuation composition of an orthopedic practice would shift materially when ASC, PT, imaging, and DME ancillaries are unbundled and analyzed separately, per commentary from VMG Health on physician practice management transactions.
• Corporate practice of medicine restrictions in California, Texas, and New York would require an MSO structure that legally separates the professional corporation (PC) from the management entity, per state-level guidance summarized by the American Medical Association.
• Ambulatory surgery center ownership by referring surgeons would trigger a safe harbor analysis under the federal Anti-Kickback Statute, per OIG safe harbor regulations.
• Site-of-service parity pressure from the Centers for Medicare & Medicaid Services would continue to affect hospital outpatient department (HOPD) versus ASC reimbursement differentials, per the CMS Hospital Outpatient Prospective Payment System.
• CT Acquisitions positions as a lower-middle-market sell-side option for orthopedic groups with $2M to $20M of practice-plus-ancillary EBITDA, alongside larger healthcare boutiques, per our M&A advisory practice overview.

Key Findings

Orthopedic MSO deal flow would remain concentrated among a small group of PE-backed platforms, including those backed by Revelstoke Capital Partners , FFL Partners , and Varsity Healthcare Partners , according to firm-disclosed portfolios. Ancillary revenue lines (ASC, PT, imaging, DME) would carry different multiples from the clinical practice itself, per commentary from VMG Health and Provident Healthcare Partners on physician-practice transactions. The vertical would remain gated by state CPOM.

1. Orthopedic MSO deal flow would remain concentrated among a small group of PE-backed platforms, including those backed by Revelstoke Capital Partners, FFL Partners, and Varsity Healthcare Partners, according to firm-disclosed portfolios.
2. Ancillary revenue lines (ASC, PT, imaging, DME) would carry different multiples from the clinical practice itself, per commentary from VMG Health and Provident Healthcare Partners on physician-practice transactions.
3. The vertical would remain gated by state CPOM statutes, with lay ownership restricted in California, Texas, and New York, per the American Medical Association.
4. Reimbursement risk in 2026 would center on the Medicare Physician Fee Schedule, per the CMS Physician Fee Schedule, and Medicare-covered ASC procedure list expansions.
5. Stark Law and Anti-Kickback Statute compliance around in-office ancillary services would remain a gating item in diligence, per OIG safe harbor regulations and CMS Stark guidance at CMS Physician Self-Referral.
6. Buy-side interest in orthopedics would remain raised because of favorable demographics, per U.S. population aging data from the U.S. Census Bureau.
7. Quality of earnings work for orthopedic MSOs would need to isolate physician compensation from partnership distributions, per Big Four practice-management guidance summarized by VMG Health.
8. Working capital pegs would carry procedural-payer collection lag risk, per National Health Statistics Group data at CMS National Health Expenditure Data.
9. Rollover equity of 20 percent to 40 percent would be standard in orthopedic PE transactions, mirroring the physician-services rollup pattern documented by Provident Healthcare Partners.
10. The Federal Trade Commission’s continued interest in healthcare consolidation would keep antitrust review a live diligence item, per the FTC healthcare guidance.

What an M&A Advisor Does for an Orthopedic Practice

An M&A advisor for an orthopedic practice runs a two-track process. Track one is the clinical entity, meaning the professional corporation that holds the physician contracts and the third-party payer contracts. Track two is the ancillary stack, meaning the ASC, PT clinic, imaging suite, DME line, and any biologics or braceshop revenue. Value is created by presenting both tracks as an integrated MSO in which the buyer acquires the management.

An M&A advisor for an orthopedic practice runs a two-track process. Track one is the clinical entity, meaning the professional corporation that holds the physician contracts and the third-party payer contracts. Track two is the ancillary stack, meaning the ASC, PT clinic, imaging suite, DME line, and any biologics or braceshop revenue. Value is created by presenting both tracks as an integrated MSO in which the buyer acquires the management entity and enters into a long-term management services agreement with the clinical entity that survives closing.

Sell-side positioning of the ancillary stack

Practice-level EBITDA would understate enterprise value when ASC, PT, and imaging are stripped out and valued at platform multiples, per commentary from VMG Health on physician-practice sum-of-the-parts analysis. The advisor’s job is to build the ancillary bridge: separate P&Ls, separate lease and staffing analysis, and a clean fair-market-value opinion supporting the intercompany allocations between the PC and the MSO.

Buyer universe curation

The advisor would maintain a live buyer list that includes PE-backed orthopedic platforms, physician-owned super groups, health-system affiliates, and payer-owned care organizations. Named PE platforms in the space include Muve Health backed by NexPhase Capital, OrthoAlliance backed by Revelstoke Capital Partners, Beacon Orthopaedics backed by Varsity Healthcare Partners, U.S. Orthopaedic Partners backed by FFL Partners, and the physician-owned super group EmergeOrtho.

Structure and consideration mix

Purchase price consideration would typically break into cash at close, rollover equity into the platform, and earnouts tied to physician retention or ASC volume growth. The rollover component is the most economically significant post-close mechanic and would generally range from 20 percent to 40 percent of the equity purchase price in physician-services rollups, per pattern data from Provident Healthcare Partners.

Multiples by Size Band

Orthopedic practice-plus-ancillary transactions are largely private and firm-specific multiples are not publicly disclosed. The bands below reflect generic physician-services and healthcare MSO framing rather than orthopedic-specific print, per commentary from VMG Health on physician-services transaction ranges. The blend of the clinical entity and its ancillaries would determine which band applies. Size band (blended EBITDA) Likely buyer Multiple framing Note Under $2M Individual physician, local super group, tuck-in add-on to an.

Orthopedic practice-plus-ancillary transactions are largely private and firm-specific multiples are not publicly disclosed. The bands below reflect generic physician-services and healthcare MSO framing rather than orthopedic-specific print, per commentary from VMG Health on physician-services transaction ranges. The blend of the clinical entity and its ancillaries would determine which band applies.

Size band (blended EBITDA)	Likely buyer	Multiple framing	Note
Under $2M	Individual physician, local super group, tuck-in add-on to an existing PE platform	Add-on framing, discount to platform	Would generally price at a discount to platform multiples because integration and physician retention risk are borne by the buyer.
$2M to $5M	PE-backed platform tuck-in, regional super group	Physician-services rollup band	Would fall inside typical physician-services rollup ranges cited by VMG Health.
$5M to $15M	Platform-of-choice for mid-size PE sponsors, super group merger	Mid-market healthcare MSO band	Would command a premium when ASC ownership and PT/imaging ancillaries are integrated and defensible.
Over $15M	New PE platform formation, health-system acquisition	Platform-of-record band	Would price at a premium reflecting platform economics and geographic scarcity, subject to CPOM and antitrust review.

Blending revenue and EBITDA ranges would be a category error and this guide keeps them separate. Every multiple range above is directional framing, not a printed comparable. Real diligence would require a fair market value opinion from a qualified appraiser such as VMG Health or a comparable firm.

What Moves the Multiple for an Orthopedic Practice

Ranked from highest to lowest impact based on our sell-side pattern experience and public commentary from healthcare valuation firms including VMG Health and Provident Healthcare Partners . Surgeon-owned ASC economics. A syndicated or wholly owned ASC with meaningful case volume would materially lift blended multiples, subject to safe harbor compliance under OIG safe harbor regulations . Physician retention and non-competes. Post-close physician contracts, non-competes, and rollover terms would drive buyer.

Ranked from highest to lowest impact based on our sell-side pattern experience and public commentary from healthcare valuation firms including VMG Health and Provident Healthcare Partners.

1. Surgeon-owned ASC economics. A syndicated or wholly owned ASC with meaningful case volume would materially lift blended multiples, subject to safe harbor compliance under OIG safe harbor regulations.
2. Physician retention and non-competes. Post-close physician contracts, non-competes, and rollover terms would drive buyer confidence. Non-compete enforceability varies by state, per National Conference of State Legislatures summaries.
3. Payer mix and commercial share. Commercial insurance percentage would be a primary multiple driver. Medicare and Medicaid rate exposure would be tracked against the CMS Physician Fee Schedule.
4. Referral pattern durability. Independent referral sources versus health-system-employed referrers would materially affect projected volume, per commentary from VMG Health.
5. Ancillary integration. On-site PT, imaging, DME, and biologics would each be evaluated for compliance with the Stark in-office ancillary services exception, per CMS Physician Self-Referral guidance.
6. Subspecialty mix. Sports medicine, spine, joint replacement, and hand each carry different case economics. Joint replacement volume in the ASC setting would be tracked against expansions of the CMS ASC covered procedures list.
7. Geography and state CPOM regime. Practices in CPOM-restrictive states such as California and Texas would require a compliant MSO structure and would attract buyers experienced in those regimes, per AMA summaries.
8. Quality of earnings and physician compensation normalization. Clean QoE that isolates physician W-2 compensation from partnership distributions would preserve deal value, per healthcare QoE guidance summarized by VMG Health. See our Quality of Earnings deep dive.
9. EHR and revenue cycle maturity. Certified EHR with clean revenue cycle KPIs would support diligence and reduce buyer discount, per HealthIT.gov guidance.
10. Value-based care contracts. Participation in Medicare Shared Savings Program ACOs or bundled payment programs would signal maturity, per CMS Shared Savings Program.
11. Employed versus contractor physician mix. W-2 physician percentage would affect the cleanliness of the roll under Stark, per CMS guidance.
12. Real estate. Owned clinic real estate would be sold separately with a lease-back and generally would not be blended into the multiple.
13. Malpractice history. Claims history and tail coverage terms would be diligence gating items.
14. OIG and CIA history. Any Corporate Integrity Agreement or open OIG matter would be a red flag, per OIG.hhs.gov.
15. Antitrust review readiness. Hart-Scott-Rodino thresholds and market concentration analysis would be pre-cleared where applicable, per FTC premerger notification program.

Active Buyers: PE Platforms and Physician-Owned Super Groups

The named platforms below have disclosed orthopedic activity through firm websites, press releases, or public commentary. This is not an exhaustive list and inclusion is not an endorsement. Platform Sponsor Framing Muve Health NexPhase Capital Musculoskeletal-focused platform combining orthopedic surgeon relationships with episode-of-care management. OrthoAlliance Revelstoke Capital Partners Multi-state orthopedic MSO platform. Beacon Orthopaedics & Sports Medicine Varsity Healthcare Partners Ohio-based platform, per sponsor disclosure. U.S. Orthopaedic Partners FFL Partners.

The named platforms below have disclosed orthopedic activity through firm websites, press releases, or public commentary. This is not an exhaustive list and inclusion is not an endorsement.

Platform	Sponsor	Framing
Muve Health	NexPhase Capital	Musculoskeletal-focused platform combining orthopedic surgeon relationships with episode-of-care management.
OrthoAlliance	Revelstoke Capital Partners	Multi-state orthopedic MSO platform.
Beacon Orthopaedics & Sports Medicine	Varsity Healthcare Partners	Ohio-based platform, per sponsor disclosure.
U.S. Orthopaedic Partners	FFL Partners	Southeast-focused orthopedic MSO platform.
EmergeOrtho	Physician-owned super group	North Carolina physician-owned super group formed by group merger without a PE sponsor.

Health systems and payer-affiliated care organizations would also participate selectively, particularly where subspecialty coverage aligns with a market gap. Strategic health-system offers would typically be structured as employed-physician acquisitions rather than MSO transactions, and would carry different tax and control implications for the selling physicians. See strategic buyer versus financial buyer for the comparison framework.

Boutique M&A Advisors Active in Orthopedic Transactions

Firm-level orthopedic specialization for boutique bankers is not always publicly disclosed. The firms below have published on physician practice management and healthcare MSO transactions and are commonly cited in the vertical. Provident Healthcare Partners has published on orthopedic MSO transactions and physician-services rollups. VMG Health provides fair market value opinions and commercial reasonableness analyses across orthopedic and other physician-services transactions. Coker Group advises physician groups on transactions and strategic planning.

Firm-level orthopedic specialization for boutique bankers is not always publicly disclosed. The firms below have published on physician practice management and healthcare MSO transactions and are commonly cited in the vertical.

• Provident Healthcare Partners has published on orthopedic MSO transactions and physician-services rollups.
• VMG Health provides fair market value opinions and commercial reasonableness analyses across orthopedic and other physician-services transactions.
• Coker Group advises physician groups on transactions and strategic planning.

Other specialty healthcare boutiques and middle-market investment banks also participate. Owners should evaluate specialization based on the specific banker team, recent orthopedic mandates, and named references, not on the firm brand alone.

CT Acquisitions positioning

CT Acquisitions positions as another lower-middle-market sell-side option specializing in owner-operated healthcare and multi-site services, owner-aligned on fees, focused on $1M to $50M enterprise-value transactions with heavy ancillary components. We keep the buyer universe narrow and the fee structure aligned to the seller. See M&A advisory overview and sell-side advisory for our process. For fee framing, see M&A advisor fees 2026 and fee structure. We are one option among the healthcare-focused boutiques cited above and orthopedic groups should interview multiple firms before signing an engagement letter. See our sister guides M&A advisor for dental practice and M&A advisor for veterinary practice for adjacent physician-services frameworks.

How the Sell-Side Process Works for an Orthopedic Practice

The full process would generally run 8 to 12 months from engagement to close for an orthopedic MSO transaction. The timeline extends when CPOM structuring or ASC diligence is complex. See investment banking process for selling a company for the general framework.

The full process would generally run 8 to 12 months from engagement to close for an orthopedic MSO transaction. The timeline extends when CPOM structuring or ASC diligence is complex. See investment banking process for selling a company for the general framework.

Month 1: engagement and prep

Engagement letter, kickoff meeting, financial and operational data collection, initial ancillary bridge analysis, and identification of QoE gaps. The advisor would begin the physician census and compensation normalization work.

Months 2 to 3: QoE and materials

Sell-side quality of earnings, confidential information memorandum (CIM) drafting, teaser drafting, ancillary bridge finalization, and preliminary fair market value opinion. Physician retention and rollover mechanics are pre-negotiated with the physician group.

Month 4: outreach and first-round bids

Teaser distribution, NDA execution, CIM distribution, management presentations, and first-round indications of interest. The advisor would filter for buyers with orthopedic MSO experience, CPOM competence, and ASC diligence capacity.

Months 5 to 6: second round and LOI

Data room population, second-round management presentations, revised bids, and letter of intent negotiation. See business sale letter of intent template for LOI structure.

Months 7 to 9: exclusive diligence

Confirmatory QoE, legal diligence including Stark and Anti-Kickback review, CPOM structuring, regulatory review, ASC syndication analysis, real estate diligence, and definitive agreement negotiation. See due diligence checklist.

Months 10 to 12: signing and closing

Definitive agreement execution, Hart-Scott-Rodino filing if applicable per FTC premerger notification, state licensing filings, closing, and rollover equity issuance. Post-close integration and MSA operationalization begin at close.

Regulatory and Structural Mechanics for 2026

Orthopedic MSO transactions are gated by a stack of federal and state regulatory regimes. Each of the items below would be a diligence workstream in a competitive process.

Orthopedic MSO transactions are gated by a stack of federal and state regulatory regimes. Each of the items below would be a diligence workstream in a competitive process.

Corporate practice of medicine

CPOM doctrine restricts lay ownership of medical practices. California, Texas, and New York are the most restrictive states, with the New York Attorney General having pursued enforcement actions against non-compliant MSO structures. The AMA maintains a state-by-state summary at ama-assn.org. The typical MSO structure separates the professional corporation from the management entity through a management services agreement.

Stark Law and in-office ancillary services

The federal physician self-referral law (Stark) prohibits referrals for designated health services to entities in which the physician has a financial relationship, subject to exceptions. The in-office ancillary services exception is the primary basis for PT, imaging, and DME within an orthopedic practice, subject to strict compliance with location, supervision, and billing requirements. See CMS Physician Self-Referral guidance.

Anti-Kickback Statute and ASC safe harbor

Surgeon ownership of an ASC to which the surgeon refers would need to satisfy the ASC safe harbor at 42 CFR 1001.952(r), including the one-third-one-third test (income and use), per OIG safe harbor regulations.

Reimbursement environment

The Medicare Physician Fee Schedule for 2026 would be tracked at the CMS Physician Fee Schedule page. The ASC covered procedures list continues to expand, tracked at the CMS ASC Payment page. Site-of-service parity pressure on HOPDs versus ASCs continues to be a policy focus, per the CMS OPPS.

340B and specialty pharmacy considerations

340B eligibility would generally not apply to a private orthopedic practice, per the HRSA Office of Pharmacy Affairs, but any hospital-owned or DSH-covered acquirer would raise 340B considerations that could affect deal structure.

State licensing and change of ownership

State medical board notifications, ASC change-of-ownership filings, and DEA registration updates would be required at close. Timing would be state-specific and should be sequenced against the closing calendar.

Antitrust review

Hart-Scott-Rodino thresholds and market-concentration analyses would apply where the buyer or the target crosses the size test, per the FTC premerger notification program. State attorneys general also review physician practice mergers under state antitrust and public interest standards.

How to Choose an M&A Advisor for an Orthopedic Practice

An owner considering a sale should evaluate advisors on the following twelve dimensions. The right advisor is the one with the deepest recent orthopedic transaction pattern in your subspecialty and state regulatory regime, not the one with the best pitch deck. Recent orthopedic transaction pattern. Ask for the number of orthopedic MSO transactions closed in the last 24 months, including named platforms, transaction size ranges, and outcomes for the selling.

An owner considering a sale should evaluate advisors on the following twelve dimensions. The right advisor is the one with the deepest recent orthopedic transaction pattern in your subspecialty and state regulatory regime, not the one with the best pitch deck.

1. Recent orthopedic transaction pattern. Ask for the number of orthopedic MSO transactions closed in the last 24 months, including named platforms, transaction size ranges, and outcomes for the selling physicians.
2. Subspecialty depth. Sports medicine, spine, joint replacement, and hand carry different buyer universes and different diligence exposures. Confirm depth in your subspecialty.
3. CPOM competence in your state. Ask for the advisor’s approach to CPOM structuring in your specific state and confirm access to healthcare counsel with relevant experience.
4. ASC diligence experience. Confirm the advisor has handled ASC-heavy transactions and understands safe harbor structuring, syndication economics, and post-close ownership continuity.
5. Fair market value opinion access. Confirm the advisor has working relationships with named FMV providers such as VMG Health or comparable firms.
6. Buyer universe depth. Ask for the full buyer list the advisor would run, including named PE platforms, super groups, and strategic parties, with an explicit rationale for each.
7. Fee structure. Ask for a fee schedule with a retainer, success fee, and any tail. See M&A advisor fees 2026, M&A advisor cost, and retainer guide for framing.
8. Team model. Confirm which banker will actually run your process day-to-day, not which senior partner will only appear at kickoff and closing.
9. References. Ask for at least three references from recently closed orthopedic transactions of similar size.
10. Broker versus banker distinction. An M&A advisor runs a controlled auction with a curated buyer list and confidential process. A business broker generally uses posted listings. See M&A advisor versus business broker.
11. Post-close support. Rollover physicians will be equity holders in the platform. Ask how the advisor supports partners through the transition and MSA operationalization.
12. Independence. Confirm the advisor does not have side agreements with any buyer that would compromise the process.

Frequently Asked Questions

Is an M&A advisor necessary for an orthopedic practice sale?

A controlled sell-side process would typically produce higher blended multiples than a bilateral negotiation with a single buyer because a competitive process forces price discovery. The advisor also manages the CPOM, Stark, and Anti-Kickback workstreams that a single owner would generally not have capacity to run alone. Per commentary from Provident Healthcare Partners, sell-side advisory in physician-services rollups is standard for practices with meaningful ancillary components.

How long does it take to sell an orthopedic practice?

Eight to twelve months from engagement to close is the typical range for an orthopedic MSO transaction. Timelines extend when CPOM structuring is complex, when ASC syndication requires unwinds and resyndications, or when Hart-Scott-Rodino review is triggered per the FTC premerger notification program.

Do I need to sell my ASC with my practice?

Not necessarily. The ASC can be sold separately, sold together with the practice as an MSO, or retained by the physicians while only the practice is sold. The right structure depends on ASC economics, referring surgeon composition, and the buyer’s preferred model. The advisor would build a sum-of-the-parts analysis to inform the decision, per commentary from VMG Health on physician-practice sum-of-the-parts framing.

What percentage of my equity would I roll into the buyer’s platform?

Rollover equity in physician-services PE transactions would generally range from 20 percent to 40 percent of the equity purchase price for selling physicians, per pattern data from Provident Healthcare Partners. The rollover is intended to align the selling physicians with the platform through the buyer’s next liquidity event, typically three to seven years post-close.

What is the difference between a physician-owned super group and a PE-backed platform?

A super group such as EmergeOrtho is formed through physician-to-physician mergers without an outside financial sponsor, and equity remains with the physicians. A PE-backed platform brings outside capital that funds cash at close in exchange for majority equity, with physicians rolling minority equity into the platform. Different economics, different governance, different post-close experience.

Will my compensation change post-close?

Yes. Physician compensation would be reset to a market-competitive W-2 structure post-close, typically calibrated by the fair market value opinion supporting the transaction. The delta between historical partnership distributions and post-close W-2 compensation is the source of the buyer’s EBITDA uplift, per commentary from VMG Health on physician compensation normalization in MSO transactions.

How is a family office offer different from a PE offer?

Family offices generally have longer hold periods and may accept lower rollover requirements, while PE platforms are structured around a definite exit event. See family office versus PE buyer for the full comparison. Both would still require CPOM-compliant structuring under state law.

Is a search fund a realistic buyer for an orthopedic practice?

Search funds generally target businesses under $5M of EBITDA and are structured for a single owner-operator transition. Orthopedic practices with meaningful physician partner pools would typically not be a fit. See search fund buyer versus PE buyer.

Methodology and Data Sources

This guide draws on public commentary from healthcare valuation and advisory firms including VMG Health , Provident Healthcare Partners , and Coker Group . It draws on public disclosures by PE sponsors including NexPhase Capital , Revelstoke Capital Partners , Varsity Healthcare Partners , and FFL Partners . It draws on federal regulatory materials from the CMS Physician Self-Referral page, OIG safe harbor regulations , the CMS Physician Fee Schedule.

This guide draws on public commentary from healthcare valuation and advisory firms including VMG Health, Provident Healthcare Partners, and Coker Group. It draws on public disclosures by PE sponsors including NexPhase Capital, Revelstoke Capital Partners, Varsity Healthcare Partners, and FFL Partners. It draws on federal regulatory materials from the CMS Physician Self-Referral page, OIG safe harbor regulations, the CMS Physician Fee Schedule, the CMS ASC Payment page, and the FTC premerger notification program. State-level CPOM summaries are drawn from the American Medical Association. National health expenditure context is drawn from CMS National Health Expenditure Data. Demographic context is drawn from the U.S. Census Bureau.

All multiples and ranges above are directional framing based on public commentary, not printed comparables for specific orthopedic MSO transactions. Orthopedic MSO transactions are largely private and firm-specific multiples are not publicly disclosed. Real diligence requires a fair market value opinion from a qualified appraiser.

Disclaimer: This guide is not an appraisal, not investment advice, not legal advice, not tax advice, not financial advice, and not a prediction. Every private-company statement in this guide is written in the conditional tense. Owners should retain qualified counsel and advisors for their specific situation.